QSAM Biosciences, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Subsequent Events (Details Narrative)

Subsequent Events (Details Narrative) - USD ($)								3 Months Ended	12 Months Ended
Subsequent Events (Details Narrative) - USD ($)	Mar. 23, 2021	Mar. 01, 2021	Feb. 16, 2021	Feb. 15, 2021	Feb. 09, 2021	Feb. 01, 2021	Jan. 27, 2021	Mar. 22, 2021	Dec. 31, 2020	Dec. 31, 2019	Jan. 08, 2021	Dec. 31, 2018	Dec. 31, 2016
Exercise price of warrants												$ 1.00
Average remaining term in years												5 years
Number shares issued during period									17,392,343
Number of shares issued debt conversion value									$ 3,017,499
Debt conversion, value									$ 3,441,401
Debt conversion into shares									534,815
Debt conversion price per share									$ 0.22
Cash compensation									$ 24,327
Number of vested shares									464,619
Bridge Notes [Member]
Debt conversion, value									$ 3,017,499
Debt conversion into shares									13,312,175
2016 Omnibus Equity Incentive Plan [Member]
Number of common stock options authorized													160,000
Series B Preferred Stock [Member]
Preferred stock, par value									$ 0.001	$ 0.001
Subsequent Event [Member] \| Earth Property Holdings LLC [Member] \| Unaffiliated Party [Member]
Sale of remaining equity interest	$ 100,000
Subsequent Event [Member] \| Bridge Notes [Member]
Debt conversion into shares								6,578,702
Debt principal and accrued interest								$ 1,447,312
Subsequent Event [Member] \| Financial Services Consulting Agreement [Member]
Number of warrants to purchase common stock						750,000
Exercise price of warrants						$ 0.22
Number shares issued during period		250,000
Cash compensation						$ 21,000
Subsequent Event [Member] \| One Institutional Investor [Member]
Number of shares issued debt conversion value							$ 72,500
Number of shares issued debt conversion							329,545
Debt conversion price per share							$ 0.22
Subsequent Event [Member] \| Other Institutional Investor [Member]
Number of shares issued debt conversion value					$ 30,000
Number of shares issued debt conversion					187,541
Debt conversion price per share					$ 0.16
Subsequent Event [Member] \| Series B Preferred Stock [Member]
Debt conversion, value							$ 23,000
Debt conversion into shares							23
Subsequent Event [Member] \| Series A Preferred Stock [Member] \| One Institutional Investor [Member]
Number shares issued during period			120,000
Number shares issued during period value			$ 750,000
Subsequent Event [Member] \| Series E-1 Incentive Preferred Stock [Member] \| Charles J. Link Jr [Member]
Number of vested shares				850
Stock options vesting, description				Two equal instalments 12 months and 24 months after issuance
Subsequent Event [Member] \| Maximum [Member] \| 2016 Omnibus Equity Incentive Plan [Member]
Number of common stock options authorized						400,000
Subsequent Event [Member] \| Minimum [Member] \| 2016 Omnibus Equity Incentive Plan [Member]
Number of common stock options authorized						1,000,000
Subsequent Event [Member] \| Series B Offerings [Member]
Exercise price of warrants											$ 0.35
Warrant expiration date											Jul. 08, 2021
Average remaining term in years											6 months
Number shares issued during period							2,500
Preferred stock, par value							$ 1,000
Number shares issued during period value							$ 2,500,000
Number of shares issued debt conversion value							$ 156,000
Subsequent Event [Member] \| Series B Offerings [Member] \| Maximum [Member]
Number of warrants to purchase common stock											6,270,000
Subsequent Event [Member] \| Warrant [Member]
Number of warrants to purchase common stock											475,000
Exercise price of warrants											$ 0.45
Warrant expiration date											Jan. 15, 2022
Subsequent Event [Member] \| Warrants [Member]
Debt conversion into shares							143,750